Presentation Information

[P017]Implications of Immune Responses to DENV, JEV, and ZIKV Infections for Cross-Reactivity and Vaccine Design

○Thi Thanh Ngan Nguyen1,3, Mya Myat Ngwe Tun1,2,5,6, Thi Bich Hau Vu3, Thi Thu Thuy Nguyen3, Vu Mai Phuong Hoang3, Le Khanh Hang Nguyen3, Muhareva Raekiansyah1, Jean Claude Balingit1, Corazon C. Buerano1, Yuki Takamatsu2, Thi Quynh Mai Le3, Futoshi Hasebe4, Kouichi Morita1,2,5,6 (1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. (Japan), 3. National Institute of Hygiene and Epidemiology, Hanoi, Vietnam. (Viet Nam), 4. Vietnam Research Station, Center for Infectious Disease Researcher in Asia and Africa, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. (Viet Nam), 5. DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki, Japan (Japan), 6. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo, Japan (Japan))

Password required to view


Comment

To browse or post comments, you must log in.Log in